Studies have shown that the gene for Alzheimer’s disease may be linked to chromosome 21, the chromosome of which individuals with Down syndrome have an extra copy. Though the evidence is not concrete, there is reason to believe that individuals with Down syndrome are more likely to develop Alzheimer’s. Thus, it is important that these individuals have equitable access to the proper treatment for Alzheimer’s, cholinesterase inhibitor donepezil (Aricept).